Development of Marine Antidiabetic Drug

Diabetes mellitus is a chronic degenerative metabolic disease whose complications lead to high morbidity and mortality. Marine microorganisms are becoming increasingly important as a promising source of novel bioactive compounds with potential medical applications. Although various strategies based on plant and synthetic sources have been successfully implemented for the treatment of diabetes, ideal drug options to overcome diabetes and its associated complications are still lacking. In recent years, there has been increasing interest in finding new bioactive compounds to treat this disease, including metabolites of marine origin. Several aquatic organisms have been screened for possible antidiabetic activity, such as bacteria, microalgae, macroalgae, seagrasses, sponges, corals, sea anemones, fish, salmon skin, shark fusion proteins, and fish and shellfish waste. Both in vitro and in vivo screens have been used to test marine organisms for antihyperglycemic and antidiabetic activity.

Our Services

Our state-of-the-art scientific resources reveal the potential of small molecules at every stage of research, from early discovery and hit discovery to lead optimization and preclinical testing. Our global team of experts will keep an eye on your end-goals for approval and adoption, while providing reliable, data-driven insights to aid in your decision-making.

• Sample Collection of Marine Organism
  We provide cultivation of marine bacteria, microalgae, macroalgae, seaweeds, sponges, corals, sea anemones, fish, and isolate and purify compounds with antidiabetic activity.
• Bioanalysis
• PK​
• Metabolite identification​
• Exposure analysis
• Safety pharmacology
• In Vivo Pharmacology
  Our technical experts and collaborating laboratories can tailor in vivo testing to your specific study design or disease model, creating an efficient process.
• Data Management and Analysis
• Data analysis and compound design​
• Professional team of data scientists and software developers
• Anti-diabetes Properties Evaluation of Marine-derived Compounds
  We construct mouse disease models to evaluate the antidiabetic activity of candidate compounds.

Why Choose Us?

• Expertise in antidiabetic drugs
• One-stop shop for antidiabetic drug discovery
• AI-driven drug discovery platform
• Fast delivery of drug candidates
• Proven track record of successful programs

Research Platforms

CD BioSciences understands that taking your product to the clinic is an important part of your job. Your technology should allow you to do the job faster and more efficiently. Let our team of experts develop and deliver a tailored roadmap to help you reach your milestones.

• Imaging platform
• Data warehousing and analysis
• Data visualization and reporting
• Bioinformatics and data science platform

CD BioSciences is a professional service provider for the marine biology industry. Our marine antidiabetic drug development services can ensure that the most suitable methods and techniques are selected for your project. We provide our customers with the most precise ingredient data and highly informed process expertise. Our team of biomass experts plays a key role in the formulation, optimization and commercial evaluation of biomass value-added processes in industry and academia. If necessary, please feel free to contact us.

Please kindly note that our services can only be used to support research purposes (Not for clinical use).